我们对癌症研究的承诺导致了英国利物浦癌症研究中心的成立。该中心汇集了科学家，临床医生和当地利益相关者，以领导和提供最高质量和重要性的癌症研究。该研究所的研究基础设施旨在使研究人员能够在最佳环境中使用世界一流的设施。我们的设施使我们能够将生物医学研究从患者样本带到实验室，反之亦然，从新生成的药物化合物进入临床试验。
Undertake research that will make a significant impact on strategies to detect, stratify and treat patients with a range of blood cancers on this Haematology and Leukaemia research degree.IntroductionHaemato-oncology is one of Liverpool’s recognised academic strengths. Focused on therapy failure due to resistance or intolerance, our research in haematology and leukaemia:Encompasses laboratory, clinical, health data and cross-disciplinary approachesExploits our unique platform technologies, sample collections and datasetsIncorporates strong patient involvement and integration with the regional clinical and diagnostic service.This research takes a variety of forms:Laboratory research – identifying biological factors that influence treatment outcomes. Scientific themes are B cell receptor signalling, 17p aberrations, non-coding RNAs and non-malignant T cells. Projects are enabled by our unique sample collections which are linked to multiple clinical trials and observational studiesClinical research – evaluating blood cancer treatment in selected patient cohorts. We lead several national clinical trials and observational studies in chronic lymphocytic leukaemia (CLL), follicular lymphoma and diffuse large B cell lymphomaHealth data research – understanding blood cancer treatment at population level. We lead UNCOVER, a national health data research programme that uses routinely collected NHS data from approximately 300,000 patients with all types of blood cancerCross-disciplinary research – research involving blood cancer and other specialties. We are co-leading multiple areas of collaborative research involving molecular diagnostics, imaging, drug safety science, cardiology and infectious diseases.